Concepedia

Maureen Okam

MO

5

Publications

339

Citations

5

H-Index

2012

Active since

Affiliations

Brigham and Women's Hospital(Current)

Dana-Farber Cancer Institute

Howard University

Harvard University

Maureen Okam is an author at Brigham and Women's Hospital specializing in hepcidin, medicine, and iron metabolism.

Top concepts

Publications per year

2012–2017

5

Publications

5

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson

Joshua J. Field, Gene Lin, Maureen Okam et al. · Blood · 2013 · 99 citations · Full text

Iron Supplementation, Response in Iron-Deficiency Anemia: Analysis of Five Trials

Maureen Okam, Todd A. Koch, Minh‐Ha Tran · The American Journal of Medicine · 2017 · 97 citations

, , +12

Comparative rates of adverse events with different formulations of intravenous iron

Maureen Okam, Elyse Mandell, Nathanael D. Hevelone et al. · American Journal of Hematology · 2012 · 56 citations · Full text

, , +20

Refining the value of secretory phospholipase <scp>A</scp><sub>2</sub> as a predictor of acute chest syndrome in sickle cell disease: results of a feasibility study (<scp>PROACTIVE</scp>)

Lori Styles, Carrie Wager, Richard Labotka et al. · British Journal of Haematology · 2012 · 49 citations · Full text

National Trends in Hospitalizations for Sickle Cell Disease in the United States Following the FDA Approval of Hydroxyurea, 1998–2008

Maureen Okam, Shimon Shaykevich, Benjamin L. Ebert et al. · Medical Care · 2014 · 38 citations · Full text

Rows per page

1–5 of 5